AlphaVax
Blood & Organ Banks · North Carolina, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2 Triangle Dr, Durham, North Carolina, 2...Phone Number
(919) 595-0400Website
www.alphavax.comRevenue
$14 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
2
2
2
2
About AlphaVax
AlphaVax Inc. is a clinical-stage biopharmaceutical company specializing in vaccine development using proprietary RNA particle technology for both human and veterinary applications. The company focuses on creating anti-infective and anti-cancer vaccines, with a particular emphasis on cancer immunotherapy. AlphaVax has developed a portfolio of seven vaccine candidates, including those targeting human cytomegalovirus, influenza A virus, prostate cancer, and HIV-1, and has conducted multiple Phase 1 clinical trials. Their innovative approach aims to engage the immune system to recognize and combat various cancers, demonstrating promising results in enhancing patient survival.Explore more
AlphaVax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AlphaVax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if AlphaVax is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when AlphaVax launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if AlphaVax has recently received funding, and reach out quickly before it becomes old news!
AlphaVax, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on AlphaVax recently announced quarterly report
Click to see if AlphaVax had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at AlphaVax
Funding: Get notified immidiatlly once AlphaVax has new funding data
Recommended Actions
Reach out to Masked Content who joined AlphaVax as Masked Content
Find 3 more new buyers
Compare Similar Companies to AlphaVax
Compare insights from companies similar to AlphaVax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
AlphaVax
$14M
51-200
Private
$31.9M
1997
AG
Andrew GrahamTechnical Operations Vice President, Development
$123.9M
51-200
Public
$462.1M
1994
TC
Tracy ClementeChief People Officer & Chief Human Resources Officer
Company Profile Activity
Activity Insights
AlphaVax is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
AlphaVax is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about AlphaVax.
AlphaVax financials insights
Gather financial insights about AlphaVax, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2000
Series B
$8.2M
Series C
$11M
2007
Series E
$12.7M
AlphaVax Tech Stack
A closer look at the technologies used by AlphaVax
See more technologies
Top Blood & Organ Banks Companies
See more top companies
Frequently Asked Questions Regarding AlphaVax
Sign Up For FreeTo access detailed company insights
AlphaVax Inc. is a clinical-stage biopharmaceutical company specializing in vaccine development using proprietary RNA particle technology for both human and veterinary applications. The company focuses on creating anti-infective and anti-cancer vaccines, with a particular emphasis on cancer immunotherapy. AlphaVax has developed a portfolio of seven... Read More
